Vivex Biomedical Raised $6.6MM in Series A Funding

Vivex Biomedical raised US $6.6MM of a potential $10MM offering of Series A Convertible Preferred Stock. Among other segments, the company's biologic products such as DBMs and synthetic bone grafts have application in general orthopaedic, spine and sports-medicine procedures.

Sources: Form D,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us